2m 2m 2m 2m 2m 2m 2m
NUVECTIS PHARMA (NVCT)
NASDAQ
$21.89-$0.04 (-0.16%)
Price as of Oct 02, 2026 7:30 PM EDT- $676.4MMarket Cap
- 265.03%1-Year Change
- BiotechnologyIndustry
NUVECTIS PHARMA (NVCT)
$21.89-$0.04 (-0.16%)
NVCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.92 | ||
Change | +$1.20 (+5.79%) | ||
Open | $21.11 | ||
High | $22.00 | ||
Low | $21.04 | ||
Previous Close | $20.72 | ||
Volume | 207,521 | ||
30-Day Average Volume | 205,554 | ||
1-Week Change | 8.41% | ||
1-Month Change | -8.36% | ||
1-Year Change | 265.03% | ||
3-Year Change | 86.08% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 32.6M | ||
Total Assets | $22.4M | ||
Market Cap | $676.4M | ||
Enterprise Value | $654.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$7.0M | ||
Free Cash Flow | -$4.5M | ||
EBIT | -$7.0M | ||
EBITDA | -$7.0M | ||
Net Working Capital | $9.1M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -93 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 74 | ||
P/E | -69 | ||
PEG | 4 | ||
Price/Free Cash Flow | -149 | ||
Price/Operating Cash Flow | -149 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue